Fulvestrant Injection Oral Steroids Muscle Built CAS 129453 61 8

Fulvestrant Oral Steroids Bodybuild Muscle Built CAS 129453-61-8

Fulvestrant is a white powder with a molecular weight of 606.77. Faslodex, AstraZeneca is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.

Applications:

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.

Fulvestran Faslodex, AstraZeneca is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.

Is a selective estrogen receptor down-regulator (SERD). is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestran remains under investigation in an attempt to optimize its effectiveness.

What other drugs will affect fulvestrant?

This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.

Tell your doctor about all your current medicines and any you start or stop using, especially:

a blood thinner--warfarin, Coumadin, Jantoven.

This list is not complete. Other drugs may interact with fulvestrant, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

USE/DOSING

Fulvestrant is administered using intramuscular injections. For the most part the full effects of the drug can be achieved using 250 milligrams per injection. Due to the active life of the compound these injections only have to be administered approximately once every four to five weeks. This is obviously a benefit when compared to the frequent dosing schedule that is required with aromatase inhibitors or selective estrogen receptor modulators.

At doses of 250 milligrams per month it has been shown that fulvestrant is just as effective as one milligram per day of anastrozole (3) or 2.5 milligrams per day of letrozole (4) at reducing estrogen in the body. It has also been demonstrated in clinical research that fulvestrant can be effective in the treatment of some estrogen-dependent breast cancers where tamoxifen citrate has failed (4, 5). This should indicate how powerful the compound truly is.